# MedPHA

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medpha

- Industry: Materials
- Headquarters: Zhuhai, China
- Website: www.medpha.cn
- Latest round: Series B (Jan 12, 2026)
- Investors on record: 4

## About

Based in Guangdong, China, and founded in 2019 by Liusong Yu and Jinyan Lu, Zhuhai Maide Fa Biotechnology Co.,Ltd, trading as MedPHA, is a biotechnology company that provides biodegradable and biocompatible PHA material solutions. As of 2024, the company has applied for more than 80 patents. The founder and chairman of the board, Liusong Yu, graduated from the University of Vienna and served as global vice president and president of the Asia Pacific Region of the American Redmond Group. 
In August 2026, MedPHA raised a venture funding from Baiyun Fund.

The company is committed to the research and development of industrial-grade PHA, medical-grade PHA, and ß-hydroxybutyrate. It has completed the construction of a thousand-ton PHA production line. The industrial grade PHA can be applied in special fibers, non-woven fabrics, and so on. In addition, the medical grade PHA has been used in the research and development of Class II and III absorbable medical devices.

The revenue and net income of the company in 2019 were CNY 550,000 and CNY -10.136 billion, respectively.

MedPHA aims to become a global leader in bio-based biodegradable materials by advancing large-scale production and commercialization of PHA biomaterials, expanding healthcare and medical applications, and developing innovative sustainable solutions that support global low-carbon and health initiatives.

## Funding rounds

- Series B, Jan 12, 2026 — Tppoly Capital, Guangzhou Pharmaceutical Capital
- Series A, Feb 4, 2024 — Zhuhai Huafa Group, Tppoly Capital, Motianshi Investment

## Investors

- Zhuhai Huafa Group — Series A
- Tppoly Capital (https://capitalatlas.ai/funds/tppoly-capital) — Series A, Series B
- Motianshi Investment — Series A
- Guangzhou Pharmaceutical Capital — Series B